Synlogic (SYBX) News Today → Does this make you sick? (From Allegiance Gold) (Ad) Free SYBX Stock Alerts $1.68 +0.03 (+1.82%) (As of 09:54 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 6:49 AM | americanbankingnews.comQ2 2024 EPS Estimates for Synlogic, Inc. (NASDAQ:SYBX) Raised by AnalystMay 16, 2024 | markets.businessinsider.comHold Rating Maintained for Synlogic Amidst Setbacks and Financial UncertaintiesMay 14, 2024 | investorplace.comSYBX Stock Earnings: Synlogic Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | finanznachrichten.deSynlogic, Inc.: Synlogic Reports First Quarter 2024 Financial ResultsMay 14, 2024 | baystreet.caSynlogic Flat on Q1 NumbersMay 14, 2024 | globenewswire.comSynlogic Reports First Quarter 2024 Financial ResultsMay 9, 2024 | finance.yahoo.comWe Think Synlogic (NASDAQ:SYBX) Needs To Drive Business Growth CarefullyApril 16, 2024 | finance.yahoo.comSynlogic, Inc. (SYBX)April 6, 2024 | investing.comSynlogic's head of finance sells shares worth $325March 21, 2024 | markets.businessinsider.comHold Rating on Synlogic Amidst Lead Program Discontinuation and Strategic UncertaintiesMarch 19, 2024 | globenewswire.comSynlogic Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 20, 2024 | finance.yahoo.comSynlogic Adopts Limited Duration Stockholders Rights PlanFebruary 20, 2024 | globenewswire.comSynlogic Adopts Limited Duration Stockholders Rights PlanFebruary 13, 2024 | markets.businessinsider.comHold Rating on Synlogic Amid Discontinued Lead Program and Reduced Price TargetFebruary 9, 2024 | finanznachrichten.deSynlogic, Inc.: Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate UpdateFebruary 9, 2024 | in.investing.comSynlogic plunges as it ceases operations following decision to discontinue Synpheny-3 studyFebruary 9, 2024 | realmoney.thestreet.comSynlogic just downgraded at Chardan, here's whyFebruary 9, 2024 | msn.comRare Disease Focused-Synlogic Pulls Plug On Lead Program, Shares NosediveFebruary 9, 2024 | bizjournals.comSynlogic cuts most workers after halting rare disease drug trialFebruary 9, 2024 | msn.comSynlogic shares crater amid company shut down, failed drug studyFebruary 9, 2024 | msn.comWhy Is Synlogic (SYBX) Stock Down 55% Today?February 9, 2024 | investorplace.comWhy Is Synlogic (SYBX) Stock Down 55% Today?February 8, 2024 | marketwatch.comSynlogic to Cease Operations, Cut Almost All Employees After Ending TrialFebruary 8, 2024 | marketwatch.comSynlogic Shares Tumble 55% on Discontinued Trial, Halt to OperationsFebruary 8, 2024 | msn.comSynlogic to discontinue lead drug program, cease operationsFebruary 8, 2024 | finance.yahoo.comSynlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate UpdateFebruary 8, 2024 | finance.yahoo.comSynlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate UpdateFebruary 8, 2024 | marketbeat.comTrading was temporarily halted for "SYBX" at 04:02 PM with a stated reason of "News pending."February 6, 2024 | ca.finance.yahoo.comSynlogic Inc (MIN.MU)February 3, 2024 | finanznachrichten.deSynlogic, Inc.: Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical HomocystinuriaFebruary 2, 2024 | finance.yahoo.comSynlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical HomocystinuriaJanuary 17, 2024 | benzinga.comSynlogic Stock (NASDAQ:SYBX) Dividends: History, Yield and DatesJanuary 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN), Enanta Pharmaceuticals (ENTA) and Synlogic (SYBX)January 6, 2024 | markets.businessinsider.comOptimistic Outlook for Synlogic’s Growth Potential and Financial SustainabilityJanuary 4, 2024 | finanznachrichten.deSynlogic, Inc.: Synlogic Provides Corporate Update and Outlook for 2024January 4, 2024 | msn.comSynlogic provides corporate update, outlook for 2024January 4, 2024 | finance.yahoo.comSynlogic Provides Corporate Update and Outlook for 2024December 27, 2023 | finanznachrichten.deSynlogic, Inc.: Synlogic Announces Contract with the Air Force Research LabDecember 27, 2023 | msn.comSynlogic bags contract to develop live probiotic productsDecember 27, 2023 | markets.businessinsider.comSynlogic Secures $1 Mln Subcontract Under Air Force Research LabDecember 27, 2023 | finance.yahoo.comSynlogic Announces Contract with the Air Force Research LabDecember 13, 2023 | benzinga.comSynlogic Stock (NASDAQ:SYBX), Analyst Ratings, Price Targets, PredictionsDecember 7, 2023 | finance.yahoo.comSynlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023November 13, 2023 | markets.businessinsider.comProgressive Synpheny-3 Trial and Extended Patent Protection Propel Buy Rating for SynlogicNovember 11, 2023 | markets.businessinsider.comSynlogic’s Financial Strength and Promising Clinical Trials Bolster Buy RatingNovember 9, 2023 | benzinga.comSynlogic: Q3 Earnings InsightsNovember 9, 2023 | finance.yahoo.comSynlogic Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 9, 2023 | finance.yahoo.comSynlogic Inc (SYBX) Reports Q3 2023 Financial Results with Extended Cash Runway and Clinical ...November 7, 2023 | finance.yahoo.comSynlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche CollaborationNovember 2, 2023 | finance.yahoo.comSynlogic, Inc. (SYBX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Get Synlogic News Delivered to You Automatically Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Your $200 account credit is about to expire (Ad)Update to MarketBeat All Access and Save $200 on Your Annual Subscription. Start Your Risk-Free Trial Here SYBX Media Mentions By Week SYBX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SYBX News Sentiment▼-0.160.42▲Average Medical News Sentiment SYBX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SYBX Articles This Week▼101▲SYBX Articles Average Week Get Synlogic News Delivered to You Automatically Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Benitec Biopharma News Today Sol-Gel Technologies News Today RenovoRx News Today MEI Pharma News Today Alaunos Therapeutics News Today Cumberland Pharmaceuticals News Today CytoMed Therapeutics News Today Bullfrog AI News Today TherapeuticsMD News Today NanoViricides News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SYBX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synlogic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
